Study of the effect of Zataria multiflora on Alzheimer's disease.

Clinical study of the effect of standard hydroalcoholic extract of (Zataria multiflor) aerial parts on Alzheimer's disease.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170702034861N10

Enrollment

Registered

2019-12-09

Start date

2019-12-06

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease. Other degenerative diseases of the nervous system

Interventions

Intervention 1: Intervention group a 600 mg capsule containing an extract of Zataria multiflora, which was made by Pharmacognosist at the Kerman Pharmaceutical Faculty, was received every 6 hours for

Eligibility

Sex/Gender

All

Age

50 Years to 85 Years

Inclusion criteria

Inclusion criteria: Age 50 to 85 years MMSE score between 16 and 24 Ability to answer questions and no mental problems

Exclusion criteria

Exclusion criteria: drug abuse and alcohol dependence taking anticoagulants depression

Design outcomes

Primary

Measure	Time frame
Cognitive status of patients. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Mini-Mental State Exam (MMSE) and Clinical Dementia Rating (CDR)questionnair.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKosar Sargazu moghadam

Kerman University of Medical Sciences

kosarsargazi@gmail.com+98 34 3132 5600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026